Oberoi Disease Management - Heart Failure
Heart failure affects nearly a million people across the UK and is second only to stroke in cost for the NHS.
It is a life-limiting condition that too often causes emergency hospital admissions, poor quality of life and ultimately early death.
While there is currently no cure for heart failure, there are several proven treatments that, combined with lifestyle changes and holistic care and support, can allow many people with heart failure to live well for longer.
The Oberoi Disease Management Heart Failure Service is aligned to the 2021 ESC1 and 2018 NICE (NG106)2 Guidelines, for the diagnosis and treatment of acute and chronic heart failure.
The purpose of the Oberoi Disease Management Heart Failure Service, is to enable primary care to identify, optimise and manage patients with heart failure.
Key elements of the service are focused on:
- Validation of heart failure registers;
- ensuring patients with heart failure are appropriately coded and categorised into HFrEF, HFpEF, HFmrEF
- case finding patients with heart failure who have coding or medication suggestive of heart failure who are not on the register
- Optimisation of patients with heart failure, with HFrEF, on appropriate therapy
- Up titration of patients to max tolerated doses of: ACE inhibitors/ARBs/ARNIs, Beta Blockers and MRAs
- Addition of Licensed SGLT2i for patients
- Continual management of patients with heart failure
- through Oberoi Disease Management - heart failure reporting and online dashboards
1. McDonaghet al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:
Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)
With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, 2021; ehab368.
Available from: https://doi.org/10.1093/eurheartj/ehab368 [Last accessed: May 2022]
2. Chronic heart failure in adults: diagnosis and management. NICE.
Available from: https://www.nice.org.uk/guidance/ng106 [Last accessed: May 2022]